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Section I: Executive Summary 
Background: The setting for this study is the structural heart program of a large healthcare 
organization in the Greater Sacramento area in California. Aortic stenosis (AS) is the most 
common cardiovascular valvular disease in the elderly. The treatment of AS is complex and over 
the last decade, the transcatheter aortic valve replacement (TAVR) procedure has changed the 
management of this high-risk group and has become the standard of care.  
Problem: The structural heart team performs an average of 170 TAVR procedures annually. The 
program is relatively new, and although it is performing above the national averages for specific 
program outcome measures, the evidence-based best practice of Shared Decision-Making (SDM) 
has not been formally adopted by this team, and therefore not utilized in the pre-TAVR work-up.  
Interventions: The goal of implementing the use of an SDM tool is to improve Quality of Life 
(QOL) outcomes by facilitating meaningful patient participation in decisions related to treatment 
options available to them using an individualized risk score based on their comorbidities, as well 
as to consider personal health and lifestyle goals. 
Outcome Measures: The outcome measure for this change in practice project aims to achieve a 
QOL score of 45 points or greater out of 100 at 30 days post-TAVR procedure using the Kansas 
City Cardiomyopathy Questionnaire-12 (KCCQ-12). The primary process measure is the 
utilization rate of the SDM tool for 95% by the structural heart team with patients referred for 
non-emergent TAVR. 
Results: A total of 63 patients underwent the TAVR procedure performed by this structural heart 
team between March 1 and May 31, 2021. 90.66% of these patients had an increase in their QOL 
score at or above 45 at 30-days post-TAVR procedure. The SDM tool was utilized with 100% of 
patients referred to this program for the TAVR procedure within the study period. 
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Conclusion: The implementation of the SDM tool greatly benefitted the team, patients, and 
caregivers to ensure everyone was clear on what the patient goals were and how they influenced 
treatment decisions and patient’s QOL. 
 
Keywords: shared decision-making, quality-of-life, TAVR, aortic stenosis
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Section II: Introduction 
Background 
Aortic stenosis (AS) is the most common valvular cardiovascular disease in the older 
patient population, and it results in decreased quality of life (QOL) for patients (American Heart 
Association [AHA], 2020). The conventional treatment for AS is a surgical procedure to replace 
the aortic valve. This surgical procedure improves the patient’s QOL and, ultimately, survival. 
Unfortunately, not all patients with AS are eligible for the conventional surgical aortic valve 
replacement (SAVR) procedure due to other comorbidities that increase their risk of 
complications from surgery (American Heart Association [AHA], 2020).  
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to 
replace the stenotic aortic valve. The TAVR procedure has transformed the treatment of patients 
with severe AS who are too high risk for conventional surgery. Currently, TAVR is the standard 
of care for intermediate, high-risk, and inoperable AS patients. However, one in four patients 
considered high risk for surgery die within one year following TAVR, challenging the heart team 
to provide much needed meaningful guidance to patients (Lauck et al., 2016). 
Problem Description 
 
The Expert Consensus Decision Pathway from the American College of Cardiology 
recommends a shared decision-making (SDM) approach for patients with AS who are 
considering the TAVR procedure (Otto et al., 2017). Patient management relies on SDM based 
on a comprehensive understanding of the risk-benefit ratio of different treatment modalities and 
integration of patient preferences and values (Otto et al., 2017). SDM involves educating patients 
and their families about treatment options available to them. Guidelines also recommend that 
patient goals and expectations be determined early in the process as related to life expectancy, 
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improvement in symptoms or survival, and end-of-life context (Otto et al., 2017). Medicare 
requires documentation of SDM utilizing an evidence-based tool for reimbursement eligibility 
for certain heart procedures, but it has not been a requirement for TAVR and is not widely used 
in practice. Research has shown that SDM tools increase patient knowledge about their disease 
and risk factors of different treatment options available, resulting in patients experiencing less 
internal conflict when deciding on how to proceed with treatment (Barry & Edgman-Levitan, 
2012).  
Setting  
 The setting for this change of practice project is the structural heart program of a large 
healthcare organization in the Greater Sacramento, California area. At baseline, this structural 
heart team was not utilizing SDM as a tool to guide the selection process for TAVR patients. This 
healthcare organization consistently seeks to decrease risk, improve patient satisfaction, and 
involve patients and families in directional decisions of the organization, making the absence of 
SDM within direct patient care notable and not aligned with the values of the organization. The 
aim of this quality improvement project is to explore the integration of an SDM tool into patient 
selection for patients with AS who are referred for the TAVR procedure within this specific 
structural heart program. 
Aim Statement 
Develop, implement, and evaluate a shared decision-making tool process to improve the 
quality of life for 95% of aortic stenosis patients referred to the structural heart program of a 
large healthcare organization in the Greater Sacramento, California area for the transcatheter 




Available Knowledge  
PICOT Question  
 
In patients with AS (P), how does an SDM strategy (I), compare to no strategy (C), as 
part of the TAVR selection process affect QOL post-TAVR, as evidenced by achieving a score of 
45 or greater out of 100 possible points on the Kansas City Cardiomyopathy Questionnaire, 
which consists of 12 questions (KCCQ-12), the answers to which are scored (O) at 30-days post-
TAVR (T).  
Search Methodology 
An electronic search was conducted between February 5 and December 31, 2020, in the 
Cochrane Database of Systemic Reviews, Cumulative Index to Nursing and Allied Health 
Literature Complete, and Pub Med databases. Limitations included research studies in the 
English language, including adults only, with publication dates no earlier than 2010. Search 
terms included: ethical issues + TAVR, patient selection + TAVR, heart team + TAVR, and shared 
decision-making + TAVR, which yielded 23 articles. Eight articles were chosen based on 
relevance to the PICOT question and the population groups included in the studies. The Johns 
Hopkins Nursing Evidence-Based Practice appraisal tools (Dang & Dearholt, 2018) were used to 
appraise the evidence for this review (see Appendix A).  
Integrated Review of the Literature 
 
The following three studies within the review did not specifically evaluate the use of 
SDM tools but are important studies to include in this review as they provide valuable evidence 
regarding the benefits of the TAVR procedure as related to QOL post-procedure. These studies 
also describe how patients evaluated for the TAVR procedure were able to clearly express their 
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treatment goal wishes, but also did not feel that they received adequate education from their 
treatment team to make an informed decision. 
Health-Related QOL 
In a systematic review and meta-analysis, Straiton et al. (2018) evaluated functional 
capacity, as well as health-related quality of life (HRQoL) of TAVR patients for up to 12 months 
post-procedure. Results indicated that patients had a significant improvement in both functional 
capacity (95% CI 9.69 – 73.28) and in their ability to perform daily tasks post-procedure (95% 
CI 3.16 – 7.68). Both outcomes had a positive impact on the HRQoL of patients, as their physical 
limitations were reduced, resulting in more independence for the patient.  
Informed Decision-Making and Treatment Goals 
The results of a retrospective qualitative review by Coylewright et al. (2015) determined 
that elderly patients with severe AS can define treatment goals, with the most commonly 
reported goals being the ability to do a specific activity and spend time with loved ones. Patient 
goals were categorized into four groups, varying from the ability to maintain independence to 
being able to perform one specific activity. Assessment of achievement of patient goals by the 
study team was done via medical record review 30 days following TAVR, as well as patient 
assessment by the TAVR coordinator during the follow-up visit. Results showed that 87% of 
patients achieved their treatment goals (Coylewright et al., 2015). Although the sample size was 
small, it was sufficient for the study design and results were definitive with clear 
recommendations for practice. 
In a non-experimental, comparative study, Dharmarajan et al. (2017) explored the beliefs 
of 407 patients with AS at nine valve centers in the United States. The objective of the study was 
to determine if patients received adequate education to enable an autonomous, informed decision 
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regarding different treatment options and plans of care. Patients were categorized in TAVR (212 
patients), SAVR (124 patients), and medical management (71 patients) groups. Statistically 
significant results showed that medically managed patients were less likely to report they 
received enough information about the benefits and risks of treatment options (p = 0.03), their 
physicians involved them in treatment decisions (p < 0.001), or final decisions were the right 
decisions (p < 0.001). Limitations included a non-randomly selected study population and the 
sample drawn from nine leading valve centers in the United States, which may make the care 
provided at these centers not generalizable. 
Benefits of SDM Tools 
Four of the studies evaluated the benefits of SDM tools. In a patient-level meta-analysis 
of seven randomized control trials, Coylewright et al. (2014) studied the use of SDM aids versus 
no SDM aids used. The researchers used a random effects model to evaluate the impact of 
sociodemographic patient information (sex, age, and education) on the outcomes of the 
discussion of treatment options, decisions made, and patient involvement in SDM. Study results 
showed that, compared to usual care, patients who used an SDM aid felt their knowledge 
increased, they had more information available to them regarding risk factors, and they felt less 
conflicted in making a decision regarding their treatment due to SDM (Coylewright et al., 2014). 
Only small numbers of people of color were included in the study population, which presents a 
study limitation. More research is needed to investigate the role of race and the use of SDM aids. 
In a study by Coylewright et al. (2020), one of the most surprising findings was that 
clinicians did not perceive a benefit to the use of an SDM tool. In this mixed-methods study, 
Coylewright et al. investigated clinician and patient attitudes towards the use of decision tools. 
Despite the lack of perceived benefit of the tool by clinicians, results from patients indicated 
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significant improvement in knowledge and SDM with the use of a decision tool by clinicians 
(79.0% for SDM group versus 17.9% for no SDM tool utilization). Unfortunately, a lack of 
perceived benefit by clinicians could likely limit full adoption and implementation of the 
decision tool.  
Marsch et al. (2019) used a quantitative benefit-risk analysis to evaluate patient 
preferences when deciding between TAVR and SAVR. Study results showed that 75.1% of 
patients favored TAVR over SAVR, favoring the less invasive procedure even with the possibility 
of a significant increase in certain risks, such as a disabling non-fatal stroke and the need for a 
permanent pacemaker. This finding supports the need for an SDM tool that guides patients and 
clinicians to choose the best procedure based on clinical indications and patient risk. 
In a prospective, randomized, controlled trial, Korteland et al. (2017) evaluated the use of 
an SDM tool and the effect on preoperative decisional conflict, patient knowledge, anxiety, and 
depression in patients referred for valve replacement procedure. Results showed that 
preoperative decisional conflict did not differ between the groups, but patients aided by SDM felt 
better informed and experienced less anxiety and depression when the tool was used (Korteland 
et al., 2017). 
Consensus Statement 
An Expert Consensus Systems of Care document by the American Association for 
Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular 
Angiography and Interventions, and the Society of Thoracic Surgeons (STS) provided a quality 
framework for TAVR centers in the United States (Bavaria et al., 2019). Despite the 
recommended framework, it is not mandated and therefore not widely adopted by structural heart 
centers in the United States. The TAVR procedure continues to be an evolving therapy, and its 
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approval for a specific patient population does not mean that it is the treatment of choice for all 
patients within that population. Patient- and family-centered care that includes the use of an 
SDM tool is recommended by several professional organizations in the consensus statement 
(Bavaria et al., 2019). 
Summary/Synthesis of the Evidence 
This review answered the PICOT question. Evidence indicated that AS patients are able 
to articulate the goals of treatment and want to be involved in the decision-making process to 
determine their best options. The goals of improved QOL and independence were important for 
most patients. Study results showed that TAVR increased functional capacity and ability to 
perform daily tasks, making these goals achievable. Unfortunately, results also indicated that 
patients lacked sufficient patient education to participate in SDM (Dharmarajan et al., 2017) 
Physicians reported that patient preference was the most common reason patients selected 
medical management over TAVR or SAVR. This is an interesting finding given that results 
indicated that patients in the medical management group did not receive adequate information 
about the benefits and risks of treatment options, were not involved in decision-making, and 
were not confident that final decisions were right (Dharmarajan et al., 2017). 
Several studies explored the use of SDM tools in the patient selection process for TAVR. 
Results showed that patients had more information available to make an informed decision, 
gained more knowledge, and felt that the right decision was ultimately made. Evidence showed 
that SDM is critical to incorporate patient preferences into treatment choices for optimal, 
individualized management of AS. Unfortunately, study results also indicated that clinicians did 
not see a benefit in the use of decision tools, which risks tool implementation and adoption 
(Coylewright et al., 2020). Finally, a consensus document from multiple professional societies 
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supports and recommends the implementation of SDM for all TAVR programs in the United 
States. Efforts are ongoing to develop decision tools to facilitate meaningful patient participation 
in the TAVR selection process. 
QOL outcomes for this structural heart program at 30 days post-procedure based on the 
KCCQ-12 summary are currently better than other hospitals in the United States at the 50th 
percentile. The national benchmark at the 50th percentile is 70.9%, and this program performs at 
75.9%. Although performance is better than the national benchmark at the 50th percentile, this 
program performs worse than the national 90th percentile (87.7%; STS/ACC TVT Registry, 
2020). 
Rationale 
Rogers’ (2003) diffusion of innovations theory provides a theoretical framework 
describing how a group of people adopt a new idea or practice, which is comprised of four main 
elements: innovation, communication channels, time, and social system. Specifically, Rogers 
defines diffusion as “the process in which an innovation is communicated through certain 
channels over time among the members of a social system” (p. 5). Rogers mapped out the 
process of adoption of a new idea, which he described as a decision to employ “full use of an 
innovation as the best course of action available” (p. 177) and determined that adoption of an 
idea is dependent on the innovation-decision process and attributes of the innovation itself across 
the four elements of the theory. Rogers viewed the innovation-decision process as information 
seeking and processing by individuals, a process which involves five phases (see Appendix B):   
1. Knowledge: The group is exposed to the new idea. 
2. Persuasion: Interest is expressed, and the individual seeks more information. 




4. Implementation: The innovation is used at varying rates. 
5. Confirmation: The ultimate adoption or rejection of the innovation. 
It is important to examine why some innovations are implemented successfully, while 
others never gain full acceptance. The degree to which the change is viewed as an improvement 
and is in alignment with the team’s values and norms makes adoption more likely. Adoption also 
depends on complexity, with earlier adoption more likely if the innovation is not complex. The 
opportunity to test the innovation increases the adoption rate, with sharing results of the pilot 
being a key tactic to increase visibility of results and the benefits of the innovation. Research 
showed that innovations offering more relative advantage, compatibility, simplicity, trialability, 
and observability are adopted more successfully than other innovations (Sahin, 2006). 
Theoretical Framework Guiding the Change in Practice 
Rogers’ (2003) diffusion of innovations theory provided the theoretical framework for 
implementation of an SDM tool within the selection process of AS patients who are candidates 
for the TAVR procedure. The tool was the innovation that needed to be adopted. Successful 
adoption depended on diffusion of the innovative process via effective communication channels 
over time within the social system (the heart team) thus the fitness of the diffusion of innovations 
theory for this project. The five phases of the innovation-decision process—in combination with 
the innovation characteristics of successful adoption framework—supported an ideal path for 
guiding this change in practice. 
The heart team was introduced to and taught (knowledge phase) about the SDM tool. 
How the heart team both received and perceived information about the new tool were critical as 
how that information was digested and processed had the potential to affect the rates of adoption. 
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If the relative advantage was compelling (persuasion phase), members of the team would decide 
(decision phase) to adopt the tool if it is compatible with team members’ values and perceived 
needs in practice. The purpose of the SDM tool was communicated clearly to show the benefits 
for the patient, as well as for the heart team.  
Successful spread of tool adoption (implementation phase) was influenced by the 
complexity of the tool, as well as the ability to pilot its use. The easier to use and improve upon 
via pilot feedback, the better. Ensuring that the results or impact of the tool were easy to measure 
and observe assisted in ultimate adoption of the tool (confirmation phase) after its use yielded 
positive results. While there are five major categories of adopters of an innovation—innovators, 
early adopters, early majority, late majority, and laggards—effective utilization of the theory 
elements, the innovation-decision process, and innovation characteristics assisted in very 
successful adoption within the social system of the heart team as primarily early adopters and 
early majority (Rogers, 2003).  
Section III: Methods 
Context 
 
The structural heart team of this healthcare organization uses a contracted, non-affiliated 
hospital as the physical location to perform structural heart procedures due to lack of 
cardiovascular services at any of the organization’s Sacramento facilities. Members who belong 
to this healthcare organization throughout the Central Valley of California are referred to the 
program.  
Structural heart programs are heavily regulated, and potential TAVR patients must be 
consulted by a cardiothoracic surgeon and an interventional cardiologist. This program is 
relatively new, and its first TAVR procedure was performed in October of 2016. An average of 
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170 TAVR procedures are performed annually. The structural heart team consists of cardiac 
surgeons, interventional cardiologists, cardiac imagers, anesthesiologists, advanced practice 
nurses, and TAVR coordinators.   
Stakeholders 
 
From a patient-centric perspective, patients and their families were the most important 
stakeholders as they would most greatly benefit from implementation of an SDM tool. Other key 
stakeholders included a cardiac surgeon and interventional cardiologist. The physicians have the 
most power and interest in the TAVR program as negative patient outcomes directly affect their 
health grade ratings and scores. The physicians on the structural heart team were supportive of 
this project and recognized that the heart team had not incorporated a process to include patient 
preference in the selection process. 
The TAVR coordinators were important stakeholders, as they coordinate care for the 
patient from the beginning of the referral process through post-operative follow-up and played a 
key role in the implementation of the SDM tool. Information technology support was vital to 
facilitate the build of the SDM tool into the electronic health record, as well as to provide 
ongoing support with potential upgrades or changes in the future. This change in practice project 
had the support of regional and local leadership to expand and lead in the delivery of care within 
this cardiovascular specialty. 
Interventions 
 
The project heart team recognized that the STS risk score provided an opportunity to 
have meaningful, patient-centered conversations to best inform the SDM process. Additional 
disciplines – such as life-care planning – were consulted based on the completed SDM tool, as 
warranted. The implementation of an SDM tool was greatly beneficial to ensure that the team 
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was clear on what the patient’s goals were prior to treatment and how those goals integrated with 
treatment decisions.  
A validated SDM tool by the American College of Cardiology was adopted and utilized 
by this structural heart team as the intervention in this study. The tool utilization ensured that the 
patient was actively involved in the process to determine the best options available to them, 
whether it was conventional surgery, the TAVR procedure, or medical management. At the time 
of patient referral to the structural heart team, educational materials were sent out via secure 
message to the patient to review prior to their consultation. The educational materials provided 
information to the patient related to the different treatment options available to choose from, as 
well as the risks and benefits of the different treatment options. If the structural heart team was 
unable to send the information to the patient electronically prior to their appointment, the patient 
was given the opportunity to comprehensively review the educational materials at the time of 
consultation. Given varying socioeconomic and educational backgrounds within the patient 
population, the consultation included a comprehensive oral discussion, validation of 
understanding of the educational materials, and a question-and-answer opportunity in order to 
assure the patients understood their choices and the implications of each. 
Following consultation, which included review of the SDM tool with the structural heart 
team, the patient’s decision was documented in the electronic medical record (EMR) utilizing a 
smart phrase. The smart phrase specifically indicates that the decision was made to move 
forward with the treatment option of their choice in collaboration with the structural heart team 
via SDM. At the time of consultation, a baseline QOL score was obtained by utilizing the 
KCCQ-12 questionnaire. If the patient proceeded with the TAVR procedure as their treatment 
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option, this  QOL score was recalculated 30 days post-procedure. The goal was to have a score of 
45 or above and an increase over baseline after their TAVR procedure. 
Gap Analysis  
 
An Expert Consensus Systems of Care document provides a quality framework for TAVR 
centers in the United States (Bavaria et al., 2019). This Consensus document recommends 
patient- and family-centered care, which includes the use of an SDM tool. An individualized 
approach is recommended using patient-specific risk data, as well as incorporating patient 
preferences into the treatment decisions. The project heart team used patient-specific risk data in 
the decision-making process regarding which treatment plan would be most appropriate, but the 
score had not been used as a guide to have meaningful conversations with patients and their 
families.  
The consensus statement from multiple professional societies aligns with the evidence 
showing that an SDM tool could facilitate patient participation in their healthcare decisions 
related to treatment options available and the risk-benefit ratio of each. At the start of this study, 
the heart team was not utilizing an SDM tool to incorporate patient preferences into the decisions 
being made (see Appendix C). 
This structural heart program performs better than the national Transcatheter Valve 
Therapy (TVT) registry benchmark (50th percentile) in risk-adjusted mortality, stroke rate, post-
operative bleeding, and paravalvular leak, as well as improvement in QOL score for patients 
undergoing the TAVR procedure. Though outcomes are above the national average at the 50th 
percentile, they are below the national average at the 90th percentile, and the evidence-based best 






Defining the proposed project and developing an aim statement for the project began in 
July 2020. Simultaneously, a comprehensive review of the literature was completed specifically 
related to the PICOT question. Over the next few months, several pre-implementation tasks were 
completed. The project was implemented in March 2021. Data were collected and analyzed on a 
monthly basis (see Appendix D for detailed project timeline). 
Work Breakdown Structure  
 
A work breakdown structure of the project was completed. Subheadings of the project 
included a review of the evidence, data analysis, project planning, project implementation, and 
education. See Appendix E for a breakdown of project deliverables. The review of the evidence 
section includes the identification of best practices and the quality gap, proposed interventions to 
be implemented, and the evaluation of results.  
The development of project measures, including creation of pre- and post-intervention 
measurements, submission of proposed project plan, and evaluation of project results, are all part 
of the data analysis section. Project planning tasks included selecting team members and defining 
their roles and responsibilities. Buy-in from the physicians was key to ensure successful 
execution of the project. Development of the communication plan, selection of the SDM tool, 
and end-user training were the final project planning tasks.  
Project implementation started with the actual go-live of the project. During this phase, 
the project lead – who was the DNP student – actively managed the project by scheduling regular 
project team meetings, providing weekly team updates, and resolving any issues that arose. 
Educational activities included identification of learning objectives and development of training 
materials. The next step was the delivery of the necessary training and education to the TAVR 
23 
 
coordinators and validation that the learning objectives were met. Finally, ongoing support of 
learning for the TAVR coordinators was key for change management. 
SWOT Analysis 
A SWOT (strengths, weaknesses, opportunities, and threats) analysis of the team and the 
work environment was performed to provide a framework for identifying and analyzing the 
internal and external factors that could have an impact on the viability of the SDM tool 
implementation (see Appendix F). This analysis helped to determine if the project was worth 
pursuing and what would be needed to make the project successful. 
Strengths 
The following primary strengths were identified. The structural heart team is a high 
performing team, as evidenced by impressive cohesiveness, strong teamwork, a high degree of 
collaboration, and a results-oriented mindset. There is strong physician leadership presence, and 
the team has support from senior leadership for the development and expansion of the structural 
heart program. The relatively new role of the TAVR coordinator allowed for expansion of the 
role’s responsibilities. Education and training, with a specific focus on SDM and life-care 
planning for all the TAVR coordinators, not only increased their knowledge base, but also 
accomplished better accountability and expanded the role and responsibilities of the 
coordinators. A key stakeholder for this project was the patient, and there was a great opportunity 
to make the care more patient-centered and, ultimately, improve the quality of care and service 







The analysis identified several weaknesses. The referral process of patients with AS to 
the structural heart team for evaluation of the TAVR procedure was not standardized. Lack of a 
standardized referral process makes the tracking of certain baseline and outcome data, as well as 
evaluation of patient progress, problematic. Patients are referred to this structural heart program 
from numerous service areas outside the Sacramento area yielding situations where 
interventional and inpatient after-care are not provided in or near some patients’ local facilities. 
Life-care planning was an important component of the decision-making process, and lack of 
resources in this department resulted in inadequate support from the life-care planning team.  
Opportunities 
The integrated nature of the studied healthcare system enabled access to software 
developers for the organization’s EMR system and permitted the SDM tool to be embedded 
within the system. This facilitated utilization by providers and made data retrieval and tracking 
easier. Further, this integration was beneficial for patients and the heart team alike as both had 
access to supportive care service lines such as home health and life-care planning. The existence 
of the SDM tool assisted in funneling the three local cardiovascular service lines’ workflows 
through a common pathway that provided a consistent experience for members from that point 
on, regardless of which of the three medical centers generated the referral. This pathway 
included acute management of their condition, as well as integrated supportive care offerings the 
health system offers. Finally, the relationship between the organization’s Greater Sacramento 
structural heart team and the contracted hospital leadership team is strong, with both parties 
committed to quality, holistic care. The constant and consistent exposure to other healthcare 




The biggest threat to the TAVR team and work environment during the study period was 
the COVID-19 pandemic. The pandemic brought constant change, created many uncertainties, 
and greatly impacted organizational and team priorities. Focus and priorities consistently shifted 
as the organization adjusted to the rapidly changing environment to ensure it could accommodate 
a surge in hospitalizations, as well as safely care for outpatients seeking both urgent and routine 
care. Additionally, the organization dealt with a tremendous amount of financial uncertainty due 
to the potential loss of health plan membership as a result of rising unemployment and associated 
loss of employer-sponsored benefits or individuals’ inability to afford health insurance. 
Budget and Financial Analysis 
A proforma financial budget, showing cost of a TAVR procedure, expenses related to 
SDM implementation, and a cost-benefit analysis, was created using structural heart volume data 
from 2019 through 2021. The proposed budget for the project included the costs for training the 
structural heart team on how to utilize the SDM tool. Five physicians, two TAVR coordinators, a 
supervisor, and department director received the training. The TAVR coordinators received 4 
hours of training calculated at their hourly wage. The five physicians, supervisor, and director 
each received 2 hours of training calculated at their hourly wage. There was no cost for the 
adopted SDM tool, as it was a pre-existing, validated tool from the American College of 
Cardiology and available at no cost to structural heart programs in the United States. Indirect 
costs included the purchase of an iPad for the structural heart team, at a cost of $650, to use for 
educational purposes in cases where the patient was unable to view educational materials at 
home. All educational materials, as well as the SDM tool, were loaded on the iPad and were 
provided to all patients during consultation. The training costs of the structural heart team, as 
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well as iPad purchase cost, were a one-time cost in the year 2021. Ultimately, the minimal 
implementation cost was negligible within the service line budget. 
Organizational savings result from the cost-benefit associated with the prevention of a 
TAVR procedure when multiple treatment options exist depending on patient goals. If the TAVR 
procedure is avoided due to inappropriate patient selection, the cost-benefit would be the 
estimated cost of a TAVR ($140,000) minus the training costs of staff and cost of the iPad. 
Conservatively, assuming one case of this nature per year, the cost-benefit would be $134,830 
per one case. The cost-benefit ratio is 27.1, almost 27 times the investment (Waxman, 2017; see 
Appendix G).  
While this is significant, changes in QOL and patient satisfaction with procedure 
selection and outcomes are difficult to monetize, as neither are directly associated with cost 
avoidance. However, the associated nature of the Hospital Consumer Assessment of Healthcare 
Providers and Systems (HCAHPS) patient satisfaction survey score with hospital reimbursement 
was also not helpful in this regard, as this structural heart team’s survey scores cannot be 
extracted from the contracted hospital unit population and benefits the contract hospital rather 
than the organization.  
Legal action and subsequent settlement costs could potentially stem from cases of 
patients who undergo TAVR and experience complications post-procedure and were not active 
participants in the treatment selection decision-making process. Patients have the legal right to 
determine their own choice of treatment after being provided with accurate, complete, and 
understandable information to make an informed decision (ANA, 2015). Similarly, legal action 
could result from patients not being offered the TAVR procedure due to not having all treatment 
options made available to them. SDM may provide additional cost avoidance of legal fees and 
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settlements associated with these scenarios; though, no cases specifically associated with these 
possibilities were found in the literature search. While the author of this paper could not find 
specific legal costs associated with inappropriate procedure selection for patients who were 
candidates for TAVR or SAVR, the average general surgical malpractice settlements found 
ranged from $940,000 to $1,400,000 (Normandie Law Firm, 2021). As patient-centered care-
becomes more mainstream, it is reasonable to anticipate that settlement costs of this magnitude 
or more would be associated with cases of inappropriate aortic valve replacement procedure 
selection, given the nature of adverse cardiac outcomes. 
Communication Plan 
 
A communication plan was developed to communicate relevant project information to 
different stakeholders throughout the duration of the project (see Appendix H). Communication 
was crucial to ensure all participants had the information they needed. Effective communication 
reinforced the transfer of knowledge and supported adoption of new workflows and the use of 
the SDM tool by the structural heart team. Communication methods included email and online 
meetings, as well as in-person meetings. In addition to communication with the different project 
stakeholders, there was also regular communication with the Doctor of Nursing Practice chair for 
this change in practice project. 
Study of the Interventions 
Measurement was an important part of the project implementation process. Measures 
informed the team whether the changes they implemented led to improvement and achievement 
of the target goals (Institute for Healthcare Improvement, 2021). Evaluation of the 
implementation of SDM occurred through daily oversight of the specific process and outcome 
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measures. The data were reviewed and analyzed on a weekly to monthly basis, depending on the 
source and availability of reports.  
KCCQ-12 information from baseline, 30-day post-TAVR procedure, and STS risk score 
documentation, as well as documentation of the SDM tool utilization, was extracted from the 
EMR. Weekly measurement meetings were held with the data analyst and the local project 
implementation team to review the data to identify any necessary revisions or adjustments that 
could be made immediately. The project lead and data analyst tested and validated all data prior 
to disseminating to the structural heart team.  
Furthermore, the contracted hospital provided weekly reports to the team to ensure that 
all registry elements, which included the documentation of the baseline and 30-day post-TAVR 
procedure QOL score, were met. The national quality dashboards are available on the regional 
cardiovascular services intranet website and are also part of public reporting from the national 
TVT registry. The results were shared with the frontline structural heart team clinicians to keep 
them informed of progress or gaps, as well as to recognize and celebrate success.  
Outcome Measures 
 
The outcome measure for the implementation of the SDM tool focused on achieving a 
QOL score (KCCQ-12) of at least 45 or greater out of 100 possible points, and an improvement 
from baseline at 30 days post-procedure in all patients undergoing TAVR. Several primary and 
secondary drivers played a role in ensuring achievement of the outcome measure. The primary 
process measure was the use of the SDM tool for patients referred for non-emergent TAVR, with 
a goal of the tool being utilized by the Greater Sacramento structural heart team for 95% of 
patients referred to the program for TAVR by October 30, 2021, with documentation of its use 
targeted at 100% within the EMR. Ninety-five percent was selected as the target due to some 
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cases coming via emergent circumstances, where SDM becomes impractical and cause delays 
that may compromise care.  
The KCCQ-12 is a shorter version of the KCCQ questionnaire and is a standard patient-
reported outcome measure used in clinical trials of surgical and transcatheter valve procedures. 
The developer of both instruments has validated that the 12-item subset shows similar 
psychometric properties as the full KCCQ. The KCCQ-12 is a valid instrument for assessing 
disease-specific health outcomes for patients with AS (see Appendix I). The SDM tool utilized 
was developed by the American College of Cardiology. All SDM tools from the American 
College of Cardiology undergo a rigorous development process that includes an extensive review 
of the literature by experts in the field. The information is summarized in patient-understandable 
language, and stakeholders review the tools to ensure accurate and unbiased content (American 
College of Cardiology, 2018). These tools were developed and made available to structural heart 
teams in the United States to aid clinicians and patients with meaningful conversations about 
care decisions (CardioSmart, 2020; see Appendix J) 
Another important process measure was the referral of patients with a STS risk score of 
8.0% and above for a life-care planning consultation. A score of 8.0% and above is indicative of 
a high risk for mortality from a cardiovascular surgical procedure. The current STS score’s 
development was based on data from the Adult Cardiac Surgery database from July 2011 to June 
2014. Validation was done using data from July 2014 to December 2016. Results showed that the 
STS risk score performed superior to the previous STS risk model (Shahian et al., 2018). Life-
care planning is an essential component of the patient evaluation process and vital to ensure 
achievement of patients’ goals. A qualitative process measure included feedback from clinicians 
regarding their perception of the tool’s utility and what benefits it added to the care of the patient. 
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CQI Method and/or Data Collection Tools 
Data were collected on all patients referred to the organization’s Greater Sacramento area 
structural heart team for evaluation of the patient for TAVR. Outcome and process measure data 
were manually collected from the EMR due to a delay of approximately 6 months in the reports 
being published by the national structural heart registry. 
Analysis 
 
Data were analyzed utilizing the Microsoft Excel software program. Descriptive statistics 
were used to summarize and describe the quantitative information, such as sex of participants, 
KCCQ-12 score at baseline, and KCCQ-12 score at 30 days post-TAVR procedure (see Appendix 
K). A quantitative process was used to analyze SDM tool utilization, as well as the STS risk 
score calculation and the accompanied documentation. A qualitative process measure included 
feedback from the structural heart team on the SDM tool utility, impact, and ease of use. 
The outcome measure was analyzed after collection of the 30-day post-procedure QOL 
score to evaluate if the score increased from the baseline score and that it was above 45. Process 
measures were studied on a weekly basis, enabling the implementation team to understand and 
address any gaps or issues in the implementation process. Clear communication and 




The University of San Francisco (USF, 2019) promotes learning in the Jesuit Catholic 
tradition. The Jesuit tradition values and views “faith and reason as complementary resources in 
the search for truth and authentic human development” (USF, 2019, p. 9). These values and 
views support treating patients with truth, spiritual value, and honor of individual beliefs and 
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further promotes a culture of service that respects and promotes the dignity of every patient. 
These values are best upheld when patients are included in the decision-making process, as 
related to treatment risks, benefits, and expected outcomes, when they are referred for major 
medical procedures, such as TAVR.  
Ethical provisions have been established to guide and provide boundaries of nursing duty 
and loyalty to the patients (ANA, 2015). Provision 4 of the ANA (2015) Code of Ethics is 
relevant to this project, “The nurse has authority, accountability, and responsibility for nursing 
practice; makes decisions; and takes action consistent with the obligation to promote health and 
to provide optimal care” (p. 15). The TAVR coordinators, who are registered nurses, comply with 
this provision by ensuring that the patient is actively involved in the decision-making process, 
which ultimately improves the patient’s QOL and health outcomes. General disclosures include 
assurance that all patient privacy measures were upheld in the collection of project data, the DNP 
student leading this project has no conflicts of interest, and the project was approved as a quality 
improvement project by USF faculty that did not need Institutional Review Board approval (see 
Appendix L for Statement of Determination). 
Section IV: Results 
Outcome data pre-SDM implementation for referrals between December 2020 and 
February 2021 revealed that 33 patients underwent the TAVR procedure. Pre-SDM 
implementation data showed that 84.84% of patients had an increase in the QOL score to 45 or 
greater at 30-days post-TAVR procedure. 
The SDM project implementation launched March 1, 2021. Between March 1 and May 
31, 73 patients were referred for the TAVR procedure. KCCQ-12 baseline data were obtained at 
the time of consultation for all patients and again at 30-day post-TAVR procedure. The outcome 
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goal was to achieve a QOL score (KCCQ-12) of at least 45 or greater at 30-days post-TAVR 
procedure. Outcome measure results for March indicated that 81.80% of patients had an increase 
in their QOL score to 45 or greater at 30-days post-TAVR procedure. In April, 95.45% of patients 
had an increase in their QOL score to 45 or greater at 30-days post-TAVR procedure, and in May 
94.74% of patients achieved the same. Outcome data post-SDM implementation showed that 
90.66% of patients had an increase in their QOL score to 45 or greater at 30-days post-TAVR 
procedure. 
The TAVR volume during the project implementation timeframe was almost double 
compared to the pre-project volume. A total of 63 patients underwent the TAVR procedure 
between March 1, 2021, and May 31, 2021, versus 33 patients between December 1, 2020, and 
February 28, 2021 (see Appendix K for display of data). Between December 2020 and February 
2021, the healthcare organization studied in this project had a significant increase in the number 
of hospitalized SARS-CoV-2 (COVID-19) patients and implemented measures to limit elective 
surgeries in an effort to keep census manageable and reduce COVID-19 infection risk for 
perioperative patients. After the surge, the organization’s structural heart program received an 
increased number of referrals of patients for the TAVR procedure.  The increase in the TAVR 
volume in this period was attributed to the impact to healthcare system from the COVID-19 
pandemic. Evidence illustrates that the pandemic has had an indirect effect on patients with 
cardiovascular disease as a result of delays in seeking care due to fear of exposure to the virus; 
and delays in receiving care due to increased demand and strain on healthcare systems and 
cancelation of semi-elective procedures (Wadhera et al., 2021). 
 Process measure results indicated that 100% of patients received the educational 
materials explaining all treatment options available to them and that the SDM tool was utilized 
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for 100% of referred patients which exceeded the 95% outcome measure. A total of 63 patients 
moved forward with the TAVR procedure, seven patients chose conventional surgery, and three 
patients decided on medical management. The majority of patients who underwent the TAVR 
procedure were male, at 68.25% of the studied population. The STS risk score was calculated on 
all patients referred for the TAVR procedure and was used as a guide to appropriately refer 
patients to other specialties, such as life-care planning. 
A qualitative process measure included feedback from clinicians regarding their 
perception of the tool’s utility and what benefits it added to the care of the patient. Feedback 
from clinicians regarding their perception of the tool’s utility and added benefits was collected 
weekly during the TAVR board meetings. Based on the feedback, any suggestions for 
improvement were incorporated into the workflows moving forward each week. In general, the 
tool and workflows were well received, and the clinicians reported that the tool guided 
meaningful conversations around treatment options and expectations that were lacking in detail 
and consistency prior to the SDM tool launch. 
Section V: Discussion  
 
Summary 
An SDM tool was successfully implemented by the structural heart team of a large 
healthcare organization in the Greater Sacramento area of California. The goal of the SDM tool 
implementation was to improve the QOL for patients with AS who were referred to the structural 
heart program for evaluation of the TAVR procedure. Study results indicated that the use of SDM 
resulted in a greater percentage of patients with an increase in their QOL post-TAVR procedure 
versus baseline.  
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Rogers’ (2003) diffusion of innovations theory provided the theoretical framework for 
this project and hugely contributed to the project’s success. A sense of urgency was created by 
explaining to the structural heart team why the utilization of the SDM tool was critical in the 
selection process of AS patients referred for the TAVR procedure due to the complexity of these 
patients’ conditions, concerns, and expectations. This project had the support of local, as well as 
regional, organizational leadership, which also contributed to successful implementation.  
Effective communication among all stakeholders was of the utmost importance and 
significantly contributed to making the changes necessary for both successful implementation 
and adoption of the tool. Buy-in from the TAVR coordinators was key, given that they provide 
first-line guidance and coordination of care for the patient from the start of the referral process 
through post-procedure follow-up. As the TAVR coordinators are nurses, the nursing profession 
should include shared decision-making philosophy and methodology within the professional 
curricula, as well as in standards of practice by professional nursing organizations. The value of 
trust that patients have in nurses was noted by the coordinators sharing how appreciative patients 
were for the time and opportunity to discuss treatment options with someone other than the 
surgeon or interventional cardiologist. It is widely known that nurses are the most trusted 
professionals in the United States, making their role in SDM critical (Saad, 2020). Standard 
workflows and the use of a smart phrase for documentation of SDM aided in the adoption of the 
tool by the TAVR coordinators as well as other members of the structural heart team. 
An important lesson learned during the study period was that the global SARS-CoV-2 
(COVID-19) pandemic caused major disruptions within healthcare, yielding certain resources 
unavailable to the team due to more urgent needs within the organization. One of those resources 
was the information technology team, as they were assigned to other projects to help set up video 
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and telehealth services to provide care to patients who were unable or unwilling to come to the 
hospital or medical offices to receive care. Fortunately, this did not derail the project, and the 
team was able to mitigate the challenge by creating smart phrases as a temporary method to 
document and capture SDM tool utilization in the EMR. 
Interpretation 
SDM is increasingly recognized as an evidence-based best practice and should be a 
primary process employed to inform and involve patients directly in their care planning. The 
Institutes of Medicine and the Affordable Care Act explicitly support SDM (American College of 
Cardiology, 2018). In addition, the Food and Drug Administration has initiated a Patient 
Preference Initiative that incorporates the patient perspective into regulatory decision-making, 
and SDM is now part of the approval process for new drugs and services (Matlock et al., 2020). 
An action brief by the National Quality Forum (2021) urges healthcare organizations to integrate 
SDM into their practices. 
Implementing this change in practice project aligns with the risk and safety philosophy of 
the organization where the tool was implemented. SDM ensures that patients are included in all 
treatment decisions and reduces legal liability in the event of a poor outcome or any adverse 
events. This project addressed several internal and external risk factors. Patient-physician and 
patient-care-team relationships and trust improve with SDM, as the patient is an active 
participant in their care and decisions being made affecting their health and life goals. 
Additionally, SDM had a positive effect on patient adherence to treatment plans to manage their 
disease. Evidence indicated that when patients are actively involved in decision-making, they are 






The biggest challenge experienced with this project was the incorporation of the SDM 
tool into the EMR. Due to the COVID-19 pandemic, there were and still are many competing 
priorities for the organization’s EMR maintenance and development team, as well as for the 
organization overall. The validated SDM tool will eventually be built into the EMR, but is not 
yet due to resource constraints and urgent competing needs. The structural heart team is currently 
utilizing a specific smart phrase as documentation to capture the elements of the tool, including 
patient participation in the decision-making process and that the patient expressed their wishes 
regarding their treatment plan during the SDM process. 
Conclusion 
 
The management of patients with AS is complex. Only a decade ago, medical 
management and invasive surgery replacing the aortic valve were the sole treatment options.  
The TAVR procedure has opened an entirely new pathway for the management of AS patients 
who are not candidates for open heart surgery. Appropriate patient selection is essential to 
determine if the TAVR procedure is indicated to achieve treatment goals, enhance QOL, and 
improve overall outcomes. Several professional organizations recommend an SDM model as part 
of the clinical pathway for AS patients, but that recommendation has not yet been widely 
incorporated into clinical practice.  
The TAVR procedure continues to be an evolving therapy. The approval of the TAVR 
procedure for a specific patient population does not mean that it should be the treatment of 
choice for all patients. An individualized approach using patient-specific risk data and 
incorporation of patient preferences into the treatment decisions is recommended. A consensus 
statement by multiple professional societies supports the evidence that an SDM tool could 
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facilitate meaningful participation of patients in healthcare decisions related to the treatment 
options available to them and the risks and benefits of each.  
Implementation of SDM within the TAVR program in this organization addresses a 
significant existing risk of patients receiving care that may not align with their personal and 
treatment goals. The process of SDM also addresses the internal risks associated with 
organizational opportunities around exclusion of the patient in care planning conversations. 
Additionally, SDM proactively assists in mitigating challenges in continuity of care by 
permitting advance planning of post-discharge care, and in the process, helps all parties level-set 
mutual expectations of adherence to the agreed-upon treatment plan and follow-up. SDM 
involves patients in conversations about their care and generates active participation in their plan 
via a better understanding of and concurrence with the treatment and follow-up plans. The 
implementation of SDM reduces the risk of potential legal action and positions the organization 
favorably to be ahead of the curve when SDM becomes officially mandated by various 
regulatory bodies. 
This project will be sustained by inclusion of outcome and process measure reporting into 
existing structural heart team meetings. Tool utilization and subsequent documentation are 
reviewed during weekly TAVR board meetings. On July 1, 2021, the national Transcatheter 
Valve Therapy registry from the Society of Thoracic Surgeons and the American College of 
Cardiology began requiring EMR-documented SDM utilization for all patients referred for the 
TAVR procedure. Quality reports from the TVT registry are received and reviewed on a quarterly 
basis, and SDM tool utilization and documentation will now be included in this review process. 
This project has the potential to be spread to other structural heart programs, as well as 
other cardiac surgery programs. More research is needed in the realm of cardiac surgery to 
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identify best practices to achieve functional SDM and to determine its impact on patient 
outcomes and satisfaction. The SDM smart phrase utilized by this team was adopted by two 
other structural heart programs and will also be used by the current team moving forward for any 
structural heart procedures, not solely TAVR. 
Section VI: Funding 
 Implementation educational costs for the structural heart team were approved by 
department leadership and paid out of the existing operational budget for this team’s department. 
Direct payment for the purchase of the iPad was approved by the department director and paid 
out of the department’s monthly operational budget. Costs are incurred one-time only during the 
first year of implementation. Incremental reporting costs are negligible, given that reporting must 
be completed for the TVT registry, and SDM tool utilization is just a small component of this 
and is now required. The benefits clearly outweigh the minimal costs associated with the 
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Evaluation Table  
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     Level V/A 
 
Great emphasis on 





Ongoing efforts to 
develop SDM tools 
for use by heart 
teams. 
Coylewright 
























































UC:  45% 




DA:  50% 
UC:  20% 
Level I/A 
 
Limitations:   





DA used was in 
English and limited 
ability to use in 
45 
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in DA group 
and SDM 
involvement 
higher in DA 
group 
vulnerable groups as 
those with English 
as second language. 
 
Although DAs are 
proven to be 
beneficial in SDM, 
future studies are 
needed to determine 
if it is an effective 
strategy to increase 
patient knowledge 





To study the 






























































baseline = 36 
 
KCCQ-12 
score at 30 













Limitations:   
Lack of prospective 
data, small sample. 
 
Although it was a 
small sample, it was 
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if the use of 




































































use of DA: 















Limitations:   
Small sample of 
clinicians led to 
small sample of 
patients, clinicians 
were all male. 
 
Conclusions: 
The use of a DA for 
severe AS patients 
improved SDM and 
patient outcomes.   
 
Clinicians did not 
perceive the DA as 
a significant benefit, 
and future research 
is needed to 
evaluate the value 
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making (p < 
0.001), and did 
not feel final 
decisions were 
the right ones 

















lack of education 
regarding treatment 
options, patients felt 
uncertain about their 
final decisions.  
 
The study showed 
that SDM needs to 
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The study represents 
Dutch 
cardiovascular 
practice and may 
not be generalizable 





An SDM tool did 
not lower decision 





Marsch et al. 
2019 
Objective of 
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Most patients will 
accept increases in 




Results showed that 
SDM tools should 
incorporate 
attributes important 
to patients to best 
support them in 
selecting the 
procedure that best 
meets their needs. 
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tasks (95% CI 














The review provides 
evidence that TAVR 
procedure increased 
functional capacity 






Definition of abbreviations: 
RCT:  randomized control trials     AS:  aortic stenosis 
TAVR:  transcatheter aortic valve replacement   OPTION:  Observing Patient Involvement scale 
SDM:  shared decision-making     UC:  usual care 
DA:  decision aid       KCCQ-12:  Kansas City Quality of Life Score 
STS:  Society of Thoracic Surgeons    HRQoL:  health-related quality of life 
ASW:  adapted swing weighting  
















Current State Future State Intervention 
 
• Shared Decision-
Making tool is not 




Making tool utilized 





• Develop and 
implement a Shared 
Decision-Making tool 
to improve QOL for 
patients with AS for 
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Review of the 
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Identify Team 
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Kick-Off 
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Analysis of 
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STRENGTHS (+) WEAKNESSES (-) 
 
• Cohesiveness 
• Teamwork and collaboration among the 
structural heart team 
• Result-oriented team 
• Physician support 
• Education and training of TAVR 
coordinators 
• Senior leadership support  
• Data readily available   
 
• Referral process of patients to the structural 
heart team is not standardized 
• Inadequate support from life-care planning 
team 
• Structural heart team covers referrals from 
numerous service areas 




OPPORTUNITIES (+) THREATS (-) 
 
• Access to software developers 
• Integration allows for access to other 
support services to support structural heart 
team 
• Strong relationship with leadership team of 
contracted hospital 
• Common referral pathway that provided a 
consistent experience for members  
 
• COVID-19 pandemic 






2019-2021 2019 2020 
2021 
Forecast* 
1. Number of TAVR procedures 147 170 220 
2. Cost Per TAVR Based on Case Rate & Other Revenue 
Codes 
$129,024  $134,400  $140,000  
3. Total Shared Decision-Making Costs N/A N/A $5,170  
*Extrapolated to year-end projection based on Jan-June 2021 utilization 
 
DEFINITIONS: 
1: Number of TAVR procedures performed yearly 
• Annual TAVR procedure volume for years 2019, 2020, and 2021 forecast based on 
volume for the first six months of the year  
2: Cost per TAVR Procedure 
• Contracted rate paid by this healthcare organization to contracted hospital with 5% 
increase in TAVR procedure cost at the start of each calendar year 
• This rate includes the DRG case rate plus all other applicable revenue codes 
3: Total Shared Decision-Making Costs 
• Summary of annual training costs for use of shared decision-making tool utilization, plus 
• Costs of equipment to support the use of the tool 
 
Cost-Benefit Analysis 
Projected 2021-2023 2021 2022 2023 
TAVR Procedure Cost $140,000  $147,000  $154,350  
    
Training Expenses:    
·       TAVR Coordinators (2) $680  0 0 
·       Physicians (5) $3,500  0 0 
·       Supervisor (1) $130  0 0 
·       Director (1) $210  0 0 
iPad Purchase Cost $650  0 0 
Net Cost-Benefit* $134,830  $147,000  $154,350  
Cost-Benefit Ratio*            27.1   
*Assumes Shared Decision-Making avoids 1 TAVR annually 
* 2021 volume: 220 (assumes 10% increase in cases per year) 
 
Net Cost-Benefit: 
• Total Benefits – Total Costs = Net Benefit  
• Cost of TAVR procedure – Total Training Cost + iPad Cost = Net Benefits 





• Total Benefits divided by Total Costs = Cost-Benefit Ratio 
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DNP Student DNP chair Monthly Zoom sessions 
Project 
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Shared Decision-Making Tools 
 
MAKING YOUR DECISION  
There is a lot to think about when trying to decide which path is right for you.  
Take some time to consider what you have learned about treatments for severe aortic stenosis. If 
you’re still not sure what the best choice is for you, ask yourself  

























MAKING YOUR DECISION  
TAVR and SAVR are each effective options for helping your aortic valve; the choice is 
ultimately a very personal one based on your overall health, values, and individual 
preference.  
 
There is a lot to think about when trying to decide which path is right for you.  
Take some time to consider what you have learned about treatments for severe aortic stenosis. If 
you’re still not sure what the best choice is for you, ask yourself  









































































Organization Letter of Support 
 
DNP Project Letter of Support  
This is a letter of support for Liesel Buchner to implement her DNP Comprehensive 
Project:  Implementation of a Shared Decision-Making tool at Kaiser Permanente.   
 
Name:  Mark Eyrich                                            Date:  08.18.2020  
Assistant Medical Group Administrator 
 
 
